Husband, Father & Interventional Cardiologist. Passion and Excellence. Tweets my own.

Azeem Latib retweeted
New TAVR, live at #NYValves2026 Live Case Session 10 (Mirus & DurAVR®) Thu June 25 | 9:10–10:10 AM Live Case Theater 🔹 Siegel TAVR (Mirus): Piedmont, Atlanta 🔹 DurAVR® (Anteris): Montefiore, NY Two live cases. Two new platforms. See you there! 🔗 nyvalvesconference.com/progr… nitter.net/AndreaScotti21/status/…
3
8
768
Azeem Latib retweeted
👍 TIO Transcatheter Interventions Online #TIOCongress USA 🇺🇸 : 12-13 June 2026 : Register here now 👉: 🔗 ow.ly/SuEc50Z7XLE…
1
6
648
Azeem Latib retweeted
The 3 innovations competing for #EuroPCR 2️⃣0️⃣2️⃣6️⃣ #PCRID Innovators Day @PCRonline Jon DeHaan Foundation award nicely highlighted by @AndreaScotti21 ⤵️ ➡️Join #EuroPCR Ceremony on Thursday, 10:15, Main Arena, to learn the 200k grant winner @azeemlatib @nickaram @nicolo_piazza
🏆 Jon DeHaan Foundation Award — #PCRID 2026 🔹 TriFlo — TR Tx (Sarkar) 🔹 eVAD System — extravascular LV/RV assist device (Krucoff) 🔹 CARLEN System — first-in-human for functional MR (Kodali) Three innovations. One prize. Which would you back? #EuroPCR #treatTR #Innovation
2
4
1,074
Azeem Latib retweeted
A 1st row seat at the table w/ all key stakeholders - unique experience in Exchange Sessions at #EuroPCR #PCRID @PCRonline Innovators day ➡️Early stage funding, AI in innovation, late-stage reimbursement, Chinese innovation @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
3
3
919
Azeem Latib retweeted
🏆 Jon DeHaan Foundation Award — #PCRID 2026 🔹 TriFlo — TR Tx (Sarkar) 🔹 eVAD System — extravascular LV/RV assist device (Krucoff) 🔹 CARLEN System — first-in-human for functional MR (Kodali) Three innovations. One prize. Which would you back? #EuroPCR #treatTR #Innovation
1
3
9
1,809
Azeem Latib retweeted
#treatTR beyond T-TEER vs. TTVR: 🎯M. deBonis w/ TriClover at #EuroPCR #PCRID @PCRonline 🎯 Transcath suture based tripple-orifice 🎯Reliable clover shape achieved in animals ➡️Design refinements & in-vivo/animal planned @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
4
3
926
Azeem Latib retweeted
Disrupting the aorta and valves: the next transcatheter wave 🔸ТТЗA - transcatheter ascending ao repair De Marco 🔸InFlow - polymeric transcatheter AV Buszman 🔸TriClover - TV clover repair De Bonis 🔸ReNiva Trapeze - posterior leaflet replacement Bapat #EuroPCR #PCRID
4
8
1,043
Azeem Latib retweeted
#EuroPCR 2026 is here & yet has its 1st highlight: #PCRID @PCRonline Innovators Day💡 🎯Innovation shaping the future #IC field 🎯Tracks on paths from idea to FIH to clinical practice ➡️If in Paris, join at Palais Congres @AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
3
4
424
Azeem Latib retweeted
Day 1 of #EuroPCR Week: #PCRID 2026 in Paris. 🌐Physicians, engineers, VCs, and entrepreneurs in the same room debating the future of cardiovascular innovation. 🏆Sessions on SH, HF, and venture capital, plus the Jon DeHaan Foundation Award for early-stage innovations.
5
10
571
Incredibly proud of @andrea_mignatti (Moses Cath Lab Director) for enrolling the 1st US patient in SUPPORT-2 at @Montefiore — within days of CMS approval. Huge credit to our Research team and @BRANY.
1
42
2,950
The big question: can Supira, Magenta, Catalyst address the limits of the only commercial MCS device — and counteract CHIP-BCIS3? PVAD-ARC (@Jeff Popma, @CRF) finally gives us the lens. @MontefioreNYC @EinsteinMed
1
236
Azeem Latib retweeted
🚨 MonteHeart 2026 🚨 Caring for cardiac patients? This MonteHeart meeting is for you! Full Agenda and RSVP here: eeds.com/live/867139 @UlrichJordeMD @azeemlatib #DJGoldstein #HeartFailure #Cardiology #MedTwitter #CardioTwitter
2
6
8
1,161
Azeem Latib retweeted
A novel low-profile (10F) percutaneous LV support device with up to 5.5 L/min demonstrates favorable performance and device-related safety in an early high-risk PCI feasibility study. The SUPPORT I Study. @azeemlatib @Kandzari ahajrnls.org/3QVIyzX
2
34
91
21,009
5 patients enrolled and treated today in Structural Heart trials at @MontefioreNYC , including the first 3 US patients in PARADIGM: the @AnterisTech DurAVR THV RCT. DurAVR is a biomimetic balloon-expandable valve designed to restore laminar flow in severe AS. @MonteHeart
6
4
66
4,983
Team: @EdwinHoMD @AndreaScotti21 @m_assafin @leoneppmd @andrea_mignatti @Tada_Sugiura @jesusdaiyan, Jimmy Doolittle, Tiffany Guglielmi. Admin (Marci, Sarah) and research (Tammy, Angela, Allen, Anna, Sarah, Bhagyashree, Mucteba, Regina) made it happen. Thanks @chrismeduri!
4
357
Bringing big ideas to life comes with big challenges. That’s why #NYValves2026 is offering exclusive discounts of up to 40% off registration for emerging tech companies! 💥 Make a splash at the world’s premier structural heart summit 🤝 Forge connections with pioneers in the field 🌱 Gain insights from the trends, technologies, and innovations transforming care Access additional savings with the early-bird rate when you submit your inquiry by March 31. Act now! 👉 ow.ly/Ix8L50YwY27 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @Drroxmehran @PopmaJeffrey @triciarawh @hahn_rt @azeemlatib @tnazifMD @drnvanmieghem @TCTConference @TCTMD
5
10
1,161
Azeem Latib retweeted
What’s next in cardiovascular innovation? Join #PCRID to explore the ideas shaping tomorrow’s practice - from AI to next-gen therapies and venture capital insights. 📅 18 May 2026📍 Paris Discover the Programme ↓ pcronline.com/Courses/PCR-In… @nickaram @azeemlatib @nicolo_piazza #PCRID #MedTech
6
8
819